TradeIndia
voice search
Yellow Fenofibrate Tablet
SharePDF

Yellow Fenofibrate Tablet

Price: 150.00 INR / Box

Get Latest Price

Minimum Order Quantity :

10000 Box

In Stock

In Stock

Product Specifications

FOB PortMUMBAI
Payment TermsCash Advance (CA), Cash in Advance (CID), Cheque, Western Union, Others
Supply Ability10000 Per Day
Delivery Time01 Week
Sample AvailableYes
Sample PolicyFree samples available with shipping and taxes paid by the buyer
Packaging Details10X10TAB
Main Export Market(s)Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
CertificationsWHO-GMP

Product Overview

Key Features

Fenofibrate is FDA approved to treat patients with hypertriglyceridemia, primary hypercholesterolemia, or mixed dyslipidemia. It reduces low-density lipoprotein cholesterol (LDL-C), total cholesterol, triglycerides, and apolipoprotein B and increases high-density lipoprotein cholesterol (HDL-C) in adults.

Disclaimer

The contents on this website is provided solely for informational purposes and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. If you have any questions about a medical problem, please consult a physician or other authorized health expert. Do not dismiss or postpone getting competent medical advice because of something you read on this website.

Company Details

This is to introduce ourselves as a professionally managed fast growing Pharmaceutical Company having more than Five Years of Manufacturing and Marketing experience. We are based at Mumbai in the State of Maharashtra. The Company has been accredited with ISO-9001:2008 and manufactures pharmaceutical formulations as per the guidelines of WHO. It is a (GMP Certified) Unit with total quality management and In-house Testing Laboratory. Our success is the result of focusing on our clients top priorities such as quality products, on-time delivery, competitive rates and unparalleled responsiveness. Johnlee manufactures more than 400 plus Pharmaceutical Formulation Products in the form of Tablets, Capsules, Dry syrup, Liquid Orals and Sustained Release Preparations. It is the Company constant and Company will also increasingly focus in high growth potential segments like Vaccines and Biogenetics. These new areas will add significant depth to the existing product pipeline. The proteasome has been validated as an important clinical target in cancer, and Johnlee Pharmaceuticals Pvt. Ltd. is developing next-generation proteasome inhibitors with a high degree of selectivity, with the goal of increasing therapeutic efficacy and reducing side effects.

Business Type

Exporter, Manufacturer, Supplier

Employee Count

20

Establishment

2005

Working Days

Monday To Saturday

GST NO

27AGKPJ8183H1ZY

Payment Mode

Cash Advance (CA)

Related Products

Explore Related Categories

Seller Details

GST

GST - 27AGKPJ8183H1ZY

3 RatingRating

Mumbai, Maharashtra

Director

Mr Vikram K Jain

Members since

11 Years

Address

Office No.22 to 25, 2nd Floor, 72/78, Chapsey Building, Ladwadi, Shamaldas Gandhi Marg, Princess Street, Mumbai, Maharashtra, 400002, India

Report incorrect details

More Product From This seller

Compare With Similar Products

Buyer Feedback

3

Response Rate

99.75

Price Or Price Range

150.00 INR

1130 INR

1130 INR

Delivery Time

01 Week

1-2 Days

1-2 Days

Payment Terms

Others

Cash in Advance (CID)

Cash in Advance (CID)

Storage Instructions

Appearance

Tablet

Tablet

Shelf Life

Printed on pack Years

Printed on pack Years

Main Domestic Market

All India

All India